US FDA issues warning letter to Alkem's Daman unit
Mumbai, Nov. 19 -- Alkem Laboratories announced that the US FDA has issued a warning letter dated November 18, 2026 for Company's manufacturing facility located at Amaliya, Daman. The Company shall be responding to the US FDA within stipulated timeline.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.